SCHEMBL2725978

SCHEMBL2725978

Fc1ccc(-c2c3ccccc3c(-c3c(F)c(F)cc(F)c3F)c3c(F)ccc(F)c23)cc1F

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1B1 Q16678 1/20 0.34
CYP3A4 P08684 4/20 0.32
CYP2C19 P33261 4/20 0.32
CYP2C9 P11712 3/20 0.32
CYP2D6 P10635 1/20 0.32
TOP1 P11387 1/20 0.32
MAOB P27338 1/20 0.31
HSD17B1 P14061 1/20 0.31
HSD17B2 P37059 1/20 0.31
TP53 P04637 1/20 0.31
NOTUM Q6P988 1/20 0.31
ALDH1A1 P00352 2/20 0.31
KDM4E B2RXH2 2/20 0.30
HPGD P15428 1/20 0.30
HTT P42858 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
DHODH Q02127 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2724999 0.92 CYP1A1 (0.33) CYP1A2CYP1A1CYP1B1TOP1MAOB
SCHEMBL2726233 0.92 CYP1A2 (0.35) CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19
SCHEMBL2726253 0.90 CYP1A2 (0.35) CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19
SCHEMBL2941870 0.90 CYP1A2 (0.33) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6
SCHEMBL2726138 0.89 CYP1A2 (0.39) CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19
SCHEMBL2724449 0.89 CYP1A2 (0.38) CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19
SCHEMBL2709627 0.88 CYP1A2 (0.36) CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19
SCHEMBL2727461 0.88 CYP1A2 (0.33) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6
SCHEMBL2725608 0.87 CYP1A2 (0.39) CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19
SCHEMBL2725664 0.86 CYP1A2 (0.42) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
EP-2445987-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS Cyalume Technologies, Inc (US) 2012-05-02 EP disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
WO-2010151654-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECHNOLOGIES, INC. (US) 2010-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYP2F1, FLAD1, AFF1 CYP1A2 22/4885CYP1A1 5/4885CYP1B1 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.